Mission statement
To be recognised as a leading pharmaceutical manufacturer by exceeding our customers expectations through quality, cost, continuous improvement and development. This will enable us to deliver a range of healthcare pharmaceuticals that meet consumer needs.
History
Relonchem Ltd has been established in 2002 and is now a wholly owned subsidiary of Marksans Pharma Ltd, One of the large pharmaceutical manufacturers based in Mumbai, India with interests in the UK, Germany, USA, Canada and Australia.
Over the years, we have achieved considerable growth and made substantial investments to increase the product portfolio. We are committed to improving efficiency year on year.
Bells healthcare (Relonchem’s sister company) business was acquired by Marksans Pharma in January 2008.
Relonchem Ltd business was acquired by Marksans Pharma in September 2008. Marksans Pharma is an India based organisation with operations in India, Germany, Australia and USA.
The Marksans plant in Goa is MHRA, TGA and FDA approved.
